Synergy CHC Corp. Common Stock

Synergy CHC Corp. Common Stock

SNYR · NASDAQ · Healthcare / Medical Distribution

0.0002USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.0002
Open0.0002
Day Range0.0002 – 0.0002
52-Week Range0.012 – 2.90
Volume0
Market Cap1.35M
P/E (TTM)0.00
Forward P/E0.16
EPS-1.60
Dividend Yield0.00%
Beta0.64
50-Day Avg0.1255
200-Day Avg0.7465

About

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Jack Ross
  • Employees28
  • Headquarters770 Roosevelt Trail STE 8, Windham, ME, United States, 04092, USA
  • Websitehttps://synergychc.com

Leadership

  • Mr. Jack RossCEO & Chairman · b. 1966
  • Mr. Alfred BaumelerPresident & Director · b. 1965
  • Ms. Jaime FickettChief Financial Officer · b. 1979
  • Mr. Scott WoodburnHead of Strategic Partnerships · b. 1964

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--9.16K13.46M34.84M35.60M33.82M29.36M40.23M-38.41M42.78M34.83M30.38M
Growth (%)---+146835.76%+158.91%+2.17%-4.98%-13.21%+37.02%--+11.37%-18.57%-12.78%
Cost of Revenue--5.62K5.31M10.21M9.82M12.47M9.14M14.68M-25.45M10.70M11.19M10.08M
Gross Profit--3.54K8.15M24.64M25.78M21.35M20.22M25.55M-12.96M32.08M23.64M20.30M
Gross Margin--38.68%60.55%70.71%72.42%63.12%68.87%63.51%-33.73%74.99%67.87%66.83%
Operating Expense--961.64K7.66M21.70M23.96M26.27M28.18M22.46M-37.92M21.27M17.84M22.10M
Operating Income-15.00K-21.78K-958.09K486.02K2.93M1.82M-4.92M-7.96M3.09M--24.97M10.81M5.80M-1.80M
Operating Margin---10461.83%3.61%8.42%5.12%-14.54%-27.10%7.67%--65.00%25.26%16.65%-5.92%
EBITDA-3.00K-21.78K-958.09K1.09M4.51M3.31M-2.36M-6.88M2.81M--25.81M10.84M6.47M-6.17M
EBITDA Margin---10461.83%8.13%12.94%9.29%-6.97%-23.45%6.98%--67.19%25.35%18.56%-20.31%
Net Income-16.20K-23.20K-960.09K-7.54M-796.16K499.57K-6.16M-9.21M1.41M--32.63M6.34M2.12M-12.34M
Net Income Margin---10483.64%-56.01%-2.29%1.40%-18.21%-31.36%3.51%--84.95%14.82%6.10%-40.62%
R&D---0000-------
R&D as % of Total Revenue---0.00%0.00%0.00%0.00%-------
Interest Expense1.20K1.42K2.00K958.74K1.57M1.04M1.13M1.11M1.30M-6.45M4.24M4.11M5.92M
Interest Expense % of Total Revenue--21.82%7.12%4.50%2.93%3.35%3.79%3.22%-16.79%9.90%11.78%19.49%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.00K3.23K55.38K27.14M20.46M24.03M20.01M5.19M12.59M-18.54M12.24M16.34M10.16M
Total Liabilities18.00K16.05K181.04K21.72M13.35M14.60M16.04M10.39M16.27M-52.06M39.55M32.97M33.29M
Total Equity-14.00K-12.82K-125.67K5.42M7.11M9.43M3.97M-5.20M-3.68M--33.52M-27.31M-16.63M-23.13M
Cash4.00K3.23K3383.64M2.52M1.96M459.74K1.22M1.67M-1.93M632.53K687.92K2.62M
Total Debt--106.40K9.87M7.47M9.95M7.77M5.71M8.75M-22.83M27.62M27.52M26.81M
Net Debt-4.00K-3.23K106.06K6.23M4.95M8.00M7.31M4.49M7.08M-20.90M26.99M26.83M24.19M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.00K-15.78K-489.18K-644.32K6.04M-831.07K1.30M2.95M-1.59M--8.43M421.73K-4.80M-2.59M
Investing Cash Flow---4.40M-4.40M-2.35M-1.95M-198.01K--361.39K-----
Financing Cash Flow-45.69K486.28K8.68M-4.83M2.31M-2.86M-2.05M1.95M-8.96M-2.09M4.80M4.65M
Capital Expenditure007.83K7.83K302.23K1.91M198.01K0201000
Free Cash Flow-6.00K-15.78K-489.18K-652.15K5.74M-2.75M1.11M2.95M-1.59M--8.43M421.73K-4.80M-2.59M
Dividends Paid--1.17M1.17M000-------
FCF to OCF100.00%100.00%100.00%101.22%95.00%330.42%84.82%100.00%100.00%-100.00%100.00%100.00%100.00%
Dividend Paid to FCF---239.99%-180.02%0.00%0.00%0.00%-------

Earnings

Report DateMar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Nov 27, 2024Mar 31, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Dec 31, 2025May 14, 2026Sep 17, 2026
EPS Estimate0.000.000.000.000.00---------------------------0.000.000.00--------0.100.070.080.010.010.03-0.01
EPS Actual0.000.00-0.00-0.000.00-0.01-0.00-0.00-0.04-0.00-0.01-0.050.03-0.000.04-0.080.03-0.000.00-0.02-0.00-0.010.00-0.060.020.000.00-0.120.000.010.01-0.020.010.010.02-52.220.462.971.793.610.810.910.090.010.10-0.050.01-0.35-0.220.17
Surprise--------------------------------------------90.00%42.86%-162.50%0.00%-3582.00%-833.33%1800.00%
Timing--------------------------------------------Pre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap1.35M
Enterprise Value27.82M
Trailing P/E0.00
Forward P/E0.16
PEG Ratio0.00
Price / Sales0.05
Price / Book0.91
EPS-1.60
Book Value-2.21
Revenue (TTM)27.70M
Gross Profit (TTM)18.11M
EBITDA-10.84M
Profit Margin-56.98%
Operating Margin-10.33%
Return on Equity-361.12%
Return on Assets-62.02%
Shares Outstanding14.90M
Shares Float8.17M
Beta0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 3.75
  • Buy
    1

Ownership Breakdown

Institutions
4.51%
Insiders
47.98%
Retail / Other
47.51%

Top Institutional Holders

  • GRATIA CAPITAL, LLC
    550.00K3.69%
  • ACT Advisors, LLC
    151.84K1.02%
  • Vanguard Capital Management, LLC
    89.77K0.60%
  • Vanguard Fiduciary Trust Co
    23.15K0.16%
  • Geode Capital Management, LLC
    21.40K0.14%
  • EWA, LLC
    13.73K0.09%
  • Citadel Advisors Llc
    10.90K0.07%
  • Williams & Novak LLC
    10.02K0.07%
  • Tower Research Capital LLC
    2.89K0.02%
  • UBS Group AG
    9000.01%
  • Hartland & Co
    1090.00%
  • Citigroup Inc
    10.00%
  • DRW Securities, LLC
    00.00%
  • Jane Street Group LLC
    00.00%
  • Warberg Asset Management LLC
    00.00%
  • SMH Capital Inc.
    00.00%
  • Heartland Advisors Inc
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    23.86K0.16%
  • Fidelity Series Total Market Index
    5.82K0.04%

Stock Splits

  • Sep 13, 20241:11
  • Apr 22, 201430:1